Cas:775-64-4 2-(1-Adamantyl)-2-propanol manufacturer & supplier

We serve Chemical Name:2-(1-Adamantyl)-2-propanol CAS:775-64-4 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

2-(1-Adamantyl)-2-propanol

Chemical Name:2-(1-Adamantyl)-2-propanol
CAS.NO:775-64-4
Synonyms:Tricyclo[3.3.1.1]decane-1-methanol, α,α-dimethyl-;2-(1-Adamantyl)-2-propanol;2-(Adamantan-1-yl)-2-propanol;2-(adamantan-1-yl)propan-2-ol;2-(1-Adamantyl)propan-2-ol;2-[1-Adamantyl]propan-2-ol
Molecular Formula:C13H22O
Molecular Weight:194.313
HS Code:2906199090

Physical and Chemical Properties:
Melting point:75ºC
Boiling point:276.2±8.0 °C at 760 mmHg
Density:1.1±0.1 g/cm3
Index of Refraction:1.543
PSA:20.23000
Exact Mass:194.167068
LogP:3.39

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like Tricyclo[3.3.1.1]decane-1-methanol, α,α-dimethyl- chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-[1-Adamantyl]propan-2-ol physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-(adamantan-1-yl)propan-2-ol Use and application,2-(1-Adamantyl)propan-2-ol technical grade,usp/ep/jp grade.


Related News: With the death toll surging past 300 and 14,300 cases confirmed, authorities across the country have activated the highest public health emergency response, stepping up screening of arrivals from Wuhan. 2-(1-Adamantyl)-2-propanol manufacturer Today, Novavax is one step closer to addressing the critical and persistent global public health need for additional COVID-19 vaccines,” Novavax president and CEO Stanley Erck said in a statement. “These clinical results reinforce that [the vaccine] is extremely effective and offers complete protection against both moderate and severe COVID-19 infection. 2-(1-Adamantyl)-2-propanol supplier Today, Novavax is one step closer to addressing the critical and persistent global public health need for additional COVID-19 vaccines,” Novavax president and CEO Stanley Erck said in a statement. “These clinical results reinforce that [the vaccine] is extremely effective and offers complete protection against both moderate and severe COVID-19 infection. 2-(1-Adamantyl)-2-propanol vendor The technology supports breakthroughs in medical research and is widely used by major global pharmaceutical companies to advance drug discovery & development and provide data to support regulatory submissions. 2-(1-Adamantyl)-2-propanol factory Retrogenix��s extensive library of human proteins make it uniquely placed for assessing candidate antibodies for target binding.